Frontage Laboratories, Inc., a leading contract development and manufacturing organization (CDMO) announced that its new ...

Aragen Launches CHOMax™, an Accelerated Platform for DNA to IND-Enabling Clinical Supply in ~10 MonthsAccelerated pathway: ...

The engagement will explore the use of cellular fermentation to make key starting materials required for pharmaceutical ...

Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.

Cellistic has unveiled three new GMP manufacturing platforms designed to advance iPSC-derived cell therapies across ...

Aragen unveils CHOMax, an accelerated platform for DNA to IND-enabling clinical supply in 10 months: Our Bureau, Bengaluru Monday, January 12, 2026, 14:15 Hrs [IST] Aragen launche ...

Bharat Coking Coal IPO Allotment, GMP LIVE Updates: The allotment for the Bharat Coking Coal (BCCL) IPO is expected to be ...

In the race to bring new biologics to market, development teams are constantly balancing speed, quality, and regulatory ...

We spoke with Scott Jones, PhD, SVP & CSO at BioBridge Global (BBG) to understand the challenges of product-specific potency ...

According to the RHP, India is the world's fifth-largest economy and the fastest-growing major economy with a growth rate of ...

Kincell Bio, a leading contract development and manufacturing organization (CDMO) in cell therapy, today announced the ...

BCCL IPO subscription period runs until January 13, with a potential listing price of ₹33.6, reflecting a 46.09% premium over ...